TrialPsychopharmacology2024

Impact of aripiprazole discontinuation in remitted major depressive disorder: a randomized placebo-controlled trial.

Masahiro Takeshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.